1)Kitaichi N, Kotake S, Sasamoto Y et al:Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 40:247-250, 1999
2)Kitaichi N, Kotake S, Mizue Y et al:Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol 84:1423-1425, 2000
3)Kotake S, Kitaichi N, Ohno S:Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin42:99-103, 2002
4)Kitaichi N, Ogasawara K, Iwabuchi K et al:Different influence of macrophage migration inhibitory factor(MIF)in signal transduction pathway of various T cell subsets. Immunobiology 201:356-367, 2000
5)Kitaichi N, Matsuda A, Kotake S et al:Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies. Curr Eye Res 20:109-114, 2000
6)Kitaichi N, Kotake S, Shibuya H et al:Increase of KL-6 in sera of uveitis patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol 241:879-883, 2003
7)Kitaichi N, Ariga T, Kase S et al:Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol 244:433-437,2006
8)Kitamura M, Kitaichi N, Takeuchi M et al:Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol89:1407-1409, 2005